Overview
Determination of the ED50 and ED95 of Prophylactic Norepinephrine Infusion for Preventing Post-induction Hypotension in Elderly Patients Undergoing Major Abdominal Surgery
Status:
Recruiting
Recruiting
Trial end date:
2023-05-30
2023-05-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
The goal of this clinical trial is to determine the ED50 and ED95 of prophylactic norepinephrine infusion for preventing post-induction hypotension in elderly patients undergoing major abdominal surgery using up-and-down sequential method . The main question it aims to answer is: What is the effective concentration of prophylactic norepinephrine infusion for preventing post-induction hypotension in elderly patients. Participants will receive different concentrations of norepinephrine infusion at the beginning of anesthesia induction until 15 minutes after intubation.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityTreatments:
Norepinephrine
Criteria
Inclusion Criteria:- aged 65 to 80 years
- Undergoing major abdominal surgery
- American Society of Anesthesiologists (ASA) physical status of I/II/III
Exclusion Criteria:
- Patient refusal
- Severe untreated or uncontrolled hypertension despite medications
- Bradycardia (heart rate < 50 beat per minute)
- Cardiac morbidities, heart block greater than the first degree
- Severe hepatic and renal dysfunction
- hyperthyroidism
- vascular diseases
- BMI>30
- Monoamine oxidase inhibitors were used 2 weeks before surgery